drugset / Trial / NCT05429476
EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary hypothesis being tested in this trial is that ischemic stroke patients in posterior circulation at 4.5 - 24 hours post onset of stroke will have improved clinical outcomes when given intravenous tissue plasminogen activator (tPA) compared to standard care.
Timeline
- Start
- 2022-08-17
- Primary completion
- 2024-08-15
- Completion
- 2024-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alteplase | Protein / enzyme biologic | 0.9 mg/kg | — |